ClinicalTrials.gg
RecruitingNCT06905119SpadCareUpdated Sep 12, 2025

Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters: SpadCare Experience

An interventional study of Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters in Infusions, Intravenous, Administration, Intravenous and Home Infusion Therapy, sponsored by Fundacion Miguel Servet. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-12.

Primary conditionCatheter-Related InfectionsRegistry: Patient ParticipationReclassifiedWhy we changed it
Registry
Patient Participation — the first condition term the registry derived for this study.
ClinicalTrials.gg
Catheter-Related Infections
Why
  1. Patient Participation is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Catheter-Related Infections.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Fundacion Miguel Servet · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 9 months after the study started (first participant enrolled May 2023, registered Feb 2025).
  • Started May 2023; still recruiting 3 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
201
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-14

Among 10 studies in Catheter-Related Infections with a site in Spain — 2 open to participants now, 2 under way, none of them phase 3. Catheter-Related Infections · Spain.

Started
2023
the only one that year
No phase
7 of 10
2 open now
Registered
9th of 10
by date
Lead sponsor
1 of 10
Fundacion Miguel Servet

Among the 10 studies in Catheter-Related Infections with a site in Spain, this one is the only one that started in 2023, is one of 7 with no phase, and was the 9th registered.

Catheter-Related Infections

112 studies on the registry are indexed under Catheter-Related Infections; 18 are open to participants now.

Browse Catheter-Related Infections studies →

Open to participants now

2 of the 10 studies in Catheter-Related Infections with a site in Spain are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 10 Catheter-Related Infections studies recruiting now, 9 (90%) set no upper age limit and 1 (10%) stops at 75 or younger; 1 takes children under 18; 1 takes healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Catheter-Related Infections with a site in Spain, or all of them as a file.
02

Study summary

The study focuses on patients who require outpatient infusion of therapy ("Infusions, Intravenous"[Mesh]) "Administration, Intravenous"[Mesh] ("Home Infusion Therapy"[Mesh]) "Parenteral Nutrition, Home"[Mesh] via a peripherally inserted central catheter (PICC) ("Central Venous Catheters"[MeSH] "Catheterization, Central Venous"[MeSH] "Catheterization, Peripheral" [MeSH] "Vascular Access Devices"[Mesh] )

Read the detailed description

The patients, who receive training ("Patient Education as Topic"[Mesh] "patient participation"[MeSH Terms] ) via an app on their personal mobile phone ("User-Computer Interface"[Mesh] "Smartphone"[MeSH] "Mobile Applications"[MeSH] "Computers, Handheld"[Mesh] "Digital Health"[Mesh] are able to perform specialized care ("Nursing"[Mesh]) Care"[MeSH] "Delivery of Health Care"[Mesh:NoExp] "Home Nursing"[MeSH] "Self Administration"[Mesh] to reduce complications ("adverse effects"[MeSH Subheading] "Catheter-Related Infections"[Mesh] ) so that they are monitored in real time by those responsible for the catheter. ("Telemedicine"[Mesh]

03

Conditions studied

  • Infusions, Intravenous
  • Administration, Intravenous
  • Home Infusion Therapy
  • Parenteral Nutrition, Home
  • Central Venous Catheters
  • Catheterization, Central Venous
  • Catheterization, Peripheral
  • Vascular Access Devices
  • Patient Education as Topic
  • Patient Participation
  • User-Computer Interface
  • Smartphone
  • Mobile Applications
  • Computers, Handheld
  • Digital Health
  • Nursing
  • Care Givers
  • Delivery of Health Care
  • Home Nursing
  • Self Administration
  • Adverse Effects
  • Catheter-Related Infections
  • Telemedicine

Browse trials for

Keywords

  • Catheterization, Peripheral
  • Vascular Access Devices
  • Patient Education as Topic
  • Telemedicine
  • Mobile Applications
04

In context

Catheter-Related Infections Reclassified

112 studies on the registry are indexed under Catheter-Related Infections; 18 are open to participants now.

This study's planned enrollment of 201 is above the median of 149 across 84 interventional studies indexed under Catheter-Related Infections.

Browse Catheter-Related Infections studies →

Lead sponsor

Fundacion Miguel Servet is the lead sponsor of 48 studies on the registry; 21 are open to participants now.

Compared within Catheter-Related Infections, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Patient Participation. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients >18 years.
  • Sign the form.
  • Have a Smartphone and accept the use of the APP.
  • Patient with a PICC inserted by the Infusion and Vascular Access Team of the University Hospital of Navarra and with a planned use of at least one month.

Exclusion criteria

Exclusion Criteria:

  • Patients with limitations in the use of digital resources or lack of Smartphone.
  • Patients who do not want to install the APP on their Smartphone
  • Patients who do not authorize access to their Computerized Medical Record (HCI).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
201 participants (estimated)

Study arms

  • Experimental
    Smart phone APP

    Patients who agree to participate in the study, once the PICC is placed, download the app to their personal Smartphone or that of a family member. The app contains all the information about the catheter, including the insertion date, gauge, number of lumens, batch number, and more. The weekly catheter care is performed at home, at the health center, or in the hospital and can be performed by nursing professionals or properly trained family members or caregivers of the patient. The patient reports any incidents that may occur each week. If an incident occurs, the responsible professional contacts the patient by phone and, if necessary, makes an appointment for an in-person consultation to review the catheter. The patient records the care performed in the app and a reminder is automatically recorded in the phone calendar. The app has documentation prepared by expert personnel along with video procedures for the care, and the "step-by-step" feature that allows the care to be performed.

    Other: Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters

  • No intervention
    Control arm

    Usual care description: Patients in the intervention group only have information about their catheter (placement date, catheter reference and batch) on a paper card; they do not have documentary or audiovisual resources. The treatment is carried out exclusively by nursing professionals at the hospital or health centre, and the latter are the ones who contact the hospital professionals who placed it in the event of an incident. The professionals who inserted the catheter are aware of the information about the catheter removal and whether there has been any significant complication when reviewing the catheters they have inserted at the end of the year, and are not aware of the incidents until the annual review. The under-registration in computer applications means that information on a high number of inserted catheters is not available.

Interventions

  • OtherDigital Transformation of Continuity of Care for Peripherally Inserted Central Catheters

    The application is offered to all patients at the time of PICC placement. If they accept, they go to the intervention group. If they do not accept, they go to the control group.

    Also known as: SpadCare Experience

07

What researchers measure

Primary outcomes

  1. 1. Patients who use computerized applications are more involved in their care and have fewer complications with the PICC

    Number of phlebitis episodes

    Time frame: At the end of intervention: Time from PICC placement to removal.

  2. 1. Patients who use computerized applications are more involved in their care and have fewer complications with the PICC.

    Number of episodes of catheter removal by reason for removal: pain

    Time frame: At the end of intervention: Time from PICC placement to removal.

  3. 1. Patients who use computerized applications are more involved in their care and have fewer complications with the PICC.

    Number of infection episodes

    Time frame: At the end of intervention: Time from PICC placement to removal.

  4. 1. Patients who use computerized applications are more involved in their care and have fewer complications with the PICC.

    Number of episodes of withdrawal reason due to accidental exit

    Time frame: At the end of the intervention: Time from PICC placement to removal.

  5. 1. Patients who use computerized applications are more involved in their care and have fewer complications with the PICC.

    Number of episodes of skin lesions

    Time frame: At the end of intervention: Time from PICC placement to removal.

  6. 1. Patients who use computerized applications are more involved in their care and have fewer complications with the PICC.

    Number of thrombosis episodes

    Time frame: At the end of intervention: Time from PICC placement to removal.

  7. 1. Patients who use computerized applications are more involved in their care and have fewer complications with the PICC.

    Number of episodes of catheter breakage as a reason for removal

    Time frame: At the end of intervention: Time from PICC placement to removal.

Secondary outcomes

  1. Patient experience

    Patient satisfaction with the use of the app, through the questionnaire CSUQ: Computer System Usability Questionnaire. The CSUQ scale, or System Usability Satisfaction Questionnaire, is a tool used to assess user satisfaction with a specific system. It is a Likert-type measurement scale, where participants evaluate their level of satisfaction with various aspects of a system, generally on a scale ranging from 1 (totally disagree) to 7 (totally agree).

    Time frame: At the end of using the application: Time from PICC placement to removal.

  2. Patient experience

    Patient satisfaction with the use of the app, through the questionnaire eHEALS. The eHealth Literacy Scale (eHEALS) is a tool that measures eHealth literacy by assessing individuals' subjective perception of their skills and knowledge in using online health resources. The questionnaire consists of eight questions that are answered on a Likert scale, where scores range from 1 (Strongly disagree) to 5 (Strongly agree).

    Time frame: At the end of using the application: Time from PICC placement to removal.

  3. Patient Satisfaction

    Overall satisfaction questionnaire with SpadCare, generated by the research team. SpadCare Questionnaire: 1 the worst value to 10 the best value How would you rate the SpadCare application you have just tested? From 1 to 10, where 1 means 'very dissatisfied' and 10 means 'very satisfied' How likely are you to recommend it to other patients?

    Time frame: At the end of using the application: Time from PICC placement to removal.

08

Study locations

1 of 1 sites recruiting
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2023 to primary completion in Apr 2025, 22 months.

Of 28 non-industry interventional studies with no phase under Catheter-Related Infections, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 36. This study's 22 months is close to that.

Counting every sponsor, half of 31 studies reached it within 22 months; a quarter within 13 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 19, 2025
First posted
Apr 1, 2025
StartActual
May 4, 2023
Primary completionActual
Apr 1, 2025
CompletionEst.
Jul 31, 2026
Last update
Sep 12, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 12, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06905119
Lead sponsor
Fundacion Miguel Servet
Collaborators
Universidad Pública de Navarra
Responsible party
Sponsor
First posted
Apr 1, 2025
Start date
May 4, 2023
Primary completion
Apr 1, 2025
Completion
Jul 31, 2026 (estimated)
Last update
Sep 12, 2025

Study contacts

María Inés Corcuera Martínez MI Corcuera Martínez, RN-PhD(c)
Contact
mi.corcuera.martinez@navarra.es
+34 687609658

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion